Arrhythmia and Right Heart Disease: From Genetic Basis to Clinical Practice

被引:29
作者
Capulzini, Lucio [1 ]
Brugada, Pedro [1 ]
Brugada, Josep [2 ]
Brugada, Ramon [3 ]
机构
[1] UZ Brussel VUB, Heart Rhythm Management Ctr, B-1090 Brussels, Belgium
[2] Hosp Clin Barcelona, Inst Clin Torax, Serv Cardiol, Barcelona, Spain
[3] Univ Girona, Ctr Genet Cardiovasc, Girona, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2010年 / 63卷 / 08期
关键词
Arrhythmogenic right ventricular dysplasia; Brugada syndrome; Idiopathic right ventricular tachycardia; Sudden cardiac death; RIGHT-VENTRICULAR CARDIOMYOPATHY; SUDDEN CARDIAC DEATH; CARDIOVERTER-DEFIBRILLATOR THERAPY; OUTFLOW TRACT TACHYCARDIA; ST-SEGMENT ELEVATION; TERM-FOLLOW-UP; BRUGADA-SYNDROME; CATHETER ABLATION; RISK STRATIFICATION; MAGNETIC-RESONANCE;
D O I
10.1016/S0300-8932(10)70208-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Historically, left ventricular cardiomyopathy and coronary heart disease have been regarded as the main causes of ventricular arrhythmia and sudden cardiac death. However, within last two decades, arrhythmias originating from the right ventricle have begun to attract the attention of the scientific world for a number of reasons. Ventricular arrhythmias originating from the right ventricle usually affect younger patients and can lead to sudden cardiac death. The pathophysiologic mechanism of these arrhythmias is not fully understood, which can leave room for a range of different interpretations. Moreover, the intriguing world of genetics is increasingly being drawn into the pathogenesis, diagnosis and prognosis of some of these arrhythmias. This review considers the pathogenesis, diagnosis and treatment of arrhythmogenic right ventricular cardiomyopathy or dysplasia (ARVD), Brugada syndrome, right ventricular outflow tract ventricular tachycardia, and arrhythmias in the right side of the heart due to congenital heart disease. In addition, because ventricular arrhythmias associated with right ventricular heart diseases such as Brugada syndrome and ARVD can explain up to 10-30% of sudden cardiac deaths in young adults in the general population and an even greater percentage in young athletes, this article contains a brief analysis of screening tests used before participation in sports, life-style modification, and treatment options for athletes affected by these conduction disorders.
引用
收藏
页码:963 / 983
页数:21
相关论文
共 117 条
[81]   Feasibility and variability of three dimensional echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy [J].
Prakasa, KR ;
Dalal, D ;
Wang, JW ;
Bomma, C ;
Tandri, H ;
Dong, J ;
James, C ;
Tichnell, C ;
Russell, SD ;
Spevak, P ;
Corretti, M ;
Bluemke, DA ;
Calkins, H ;
Abraham, TP .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (05) :703-709
[82]   Natural history of Brugada syndrome - Insights for risk stratification and management [J].
Priori, SG ;
Napolitano, C ;
Gasparini, M ;
Pappone, C ;
Della Bella, P ;
Giordano, U ;
Bloise, R ;
Giustetto, C ;
De Nardis, R ;
Grillo, M ;
Ronchetti, E ;
Faggiano, G ;
Nastoli, J .
CIRCULATION, 2002, 105 (11) :1342-1347
[83]  
PROTONOTARIOS N, 1986, BRIT HEART J, V56, P321
[84]   Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy [J].
Rampazzo, A ;
Nava, A ;
Malacrida, S ;
Beffagna, G ;
Bauce, B ;
Rossi, V ;
Zimbello, R ;
Simionati, B ;
Basso, C ;
Thiene, G ;
Towbin, JA ;
Danieli, GA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (05) :1200-1206
[85]  
RICHTER S, 2010, EUR HEART J 0316
[86]   Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy [J].
Roguin, A ;
Bomma, CS ;
Nasir, K ;
Tandri, H ;
Tichnell, C ;
James, C ;
Rutberg, J ;
Crosson, J ;
Spevak, PJ ;
Berger, RD ;
Halperin, HR ;
Calkins, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (10) :1843-1852
[87]   Sodium channel mutations and arrhythmias [J].
Ruan, Yanfei ;
Liu, Nian ;
Priori, Silvia G. .
NATURE REVIEWS CARDIOLOGY, 2009, 6 (05) :337-348
[88]   Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome -: A multicenter study [J].
Sacher, Frederic ;
Probst, Vincent ;
Iesaka, Yoshito ;
Jacon, Peggy ;
Laborderie, Julien ;
Mizon-Gerard, Frederique ;
Mabo, Philippe ;
Reuter, Sylvain ;
Lamaison, Dominique ;
Takahashi, Yoshihide ;
O'Neill, Mark D. ;
Garrigue, Stephane ;
Pierre, Bertrand ;
Jais, Pierre ;
Pasquie, Jean-Luc ;
Hocini, Meleze ;
Salvador-Mazenq, Michele ;
Nogami, Akihiko ;
Amiel, Alain ;
Defaye, Pascal ;
Bordachar, Pierre ;
Boveda, Serge ;
Maury, Philippe ;
Klug, Didier ;
Babuty, Dominique ;
Haissaguerre, Michel ;
Mansourati, Jacques ;
Clementy, Jacques ;
Le Marec, Herve .
CIRCULATION, 2006, 114 (22) :2317-2324
[89]   Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome [J].
Sarkozy, Andrea ;
Boussy, Tim ;
Kourgiannides, Georgios ;
Chierchia, Gian-Battista ;
Richter, Sergio ;
De Potter, Tom ;
Geelen, Peter ;
Wellens, Francis ;
Spreeuwenberg, Marieke Dingena ;
Brugada, Pedro .
EUROPEAN HEART JOURNAL, 2007, 28 (03) :334-344
[90]   Role of genetic analysis in the management of patients with arrhythmogenic right ventricular ysplasia/ardiomyopathy [J].
Sen-Chowdhry, Srijita ;
Syrris, Petros ;
McKenna, William J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (19) :1813-1821